BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 27978929)

  • 1. [Clinical effect of polyvinyl alcohol particles combined with chemoembolization in treatment of hepatocellular carcinoma complicated by hepatic arteriovenous shunt and related and prognostic factors].
    Liu QS; Mei QL; Li YH; He XF; Zeng QL; Pang HJ; Xiao LJ
    Zhonghua Gan Zang Bing Za Zhi; 2016 Nov; 24(11):834-839. PubMed ID: 27978929
    [No Abstract]   [Full Text] [Related]  

  • 2. Polyvinyl alcohol terminal chemoembolization for hepatocellular carcinoma with hepatic arteriovenous shunts: Safety, efficacy, and prognostic factors.
    Liu QS; Mei QL; Li YH
    Eur J Radiol; 2017 Apr; 89():277-283. PubMed ID: 27908612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemoembolisation with polyvinyl alcohol for advanced hepatocellular carcinoma with portal vein tumour thrombosis and arterioportal shunts: efficacy and prognostic factors.
    Xiao L; Liu Q; Zhao W; Pang H; Zeng Q; Chen Y; Zhao J; Mei Q; He X
    Clin Radiol; 2018 Dec; 73(12):1056.e17-1056.e22. PubMed ID: 30224186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatic resection after transarterial chemoembolization increases overall survival in large/multifocal hepatocellular carcinoma: a retrospective cohort study.
    Chen J; Lai L; Lin Q; Huang W; Cai M; Zhu K; Huang M
    Oncotarget; 2017 Jan; 8(1):408-417. PubMed ID: 27880724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical efficacy of postoperative adjuvant transcatheter arterial chemoembolization on hepatocellular carcinoma.
    Liu C; Sun L; Xu J; Zhao Y
    World J Surg Oncol; 2016 Apr; 14():100. PubMed ID: 27038790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatocellular carcinoma macroscopic gross appearance on imaging: predictor of outcome after transarterial chemoembolization in a real-life multicenter French cohort.
    Adhoute X; Pénaranda G; Raoul JL; Pietri O; Bronowicki JP; Castellani P; Perrier H; Monnet O; Bayle O; Oules V; Pol B; Beaurain P; Muller C; Cassagneau P; Bourlière M
    Eur J Gastroenterol Hepatol; 2019 Nov; 31(11):1414-1423. PubMed ID: 31045613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of using different embolic agents on survival in transarterial chemoembolization of hepatocellular carcinoma: gelfoam versus polyvinyl alcohol.
    Koçyiğit A; Dicle O; Göktay Y; Astarcıoğlu I
    Diagn Interv Radiol; 2014; 20(4):323-9. PubMed ID: 24808440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of 8spheres polyvinyl alcohol microsphere and gelatin sponge particle efficacy for transcatheter arterial chemoembolization in stages A to B patients with hepatocellular carcinoma.
    Zeng J; Wang Y; Wang H; Hou Y; He D
    J Cancer Res Ther; 2022 Dec; 18(7):1981-1987. PubMed ID: 36647959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TACE plus percutaneous chemotherapy-lipiodol treatment of unresectable pedunculated hepatocellular carcinoma.
    Huang D; Chen Y; Chen S; Zeng Q; Zhao J; Wu R; Li Y
    Medicine (Baltimore); 2017 Jul; 96(30):e7650. PubMed ID: 28746230
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and prognostic factors of transarterial embolization as initial treatment for spontaneously ruptured hepatocellular carcinoma: a single-center retrospective analysis in 57 patients.
    Zhou C; Zu QQ; Wang B; Zhou CG; Shi HB; Liu S
    Jpn J Radiol; 2019 Mar; 37(3):255-263. PubMed ID: 30511145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of alpha-fetoprotein status in the outcome of hepatocellular carcinoma after treatment of transarterial chemoembolization.
    Wang Y; Chen Y; Ge N; Zhang L; Xie X; Zhang J; Chen R; Wang Y; Zhang B; Xia J; Gan Y; Ren Z; Ye S
    Ann Surg Oncol; 2012 Oct; 19(11):3540-6. PubMed ID: 22532305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transarterial chemoembolization for hepatocellular carcinoma after transjugular intrahepatic portosystemic shunt.
    Kang JW; Kim JH; Ko GY; Gwon DI; Yoon HK; Sung KB
    Acta Radiol; 2012 Jun; 53(5):545-50. PubMed ID: 22547388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxaliplatin and 5-fluorouracil hepatic infusion with lipiodolized chemoembolization in large hepatocellular carcinoma.
    Li JH; Xie XY; Zhang L; Le F; Ge NL; Li LX; Gan YH; Chen Y; Zhang JB; Xue TC; Chen RX; Xia JL; Zhang BH; Ye SL; Wang YH; Ren ZG
    World J Gastroenterol; 2015 Apr; 21(13):3970-7. PubMed ID: 25852283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polyvinyl alcohol embolization adjuvant to oily chemoembolization in advanced hepatocellular carcinoma with arterioportal shunts.
    Kim YJ; Lee HG; Park JM; Lim YS; Chung MH; Sung MS; Yoo WJ; Lim HW
    Korean J Radiol; 2007; 8(4):311-9. PubMed ID: 17673842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemoembolization for hepatocellular carcinoma: multivariate analysis of predicting factors for tumor response and survival in a 362-patient cohort.
    Hu HT; Kim JH; Lee LS; Kim KA; Ko GY; Yoon HK; Sung KB; Gwon DI; Shin JH; Song HY
    J Vasc Interv Radiol; 2011 Jul; 22(7):917-23. PubMed ID: 21571545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined transjugular intrahepatic portosystemic shunt and segmental Lipiodol hepatic artery embolization for the treatment of esophagogastric varices and hepatocellular carcinoma in patients with cirrhosis: preliminary report.
    Sakaguchi H; Uchida H; Maeda M; Matsuo N; Kichikawa K; Ohishi H; Nishida H; Ueno K; Nishimine K; Rösch J
    Cardiovasc Intervent Radiol; 1995; 18(1):9-15. PubMed ID: 7540504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Chemoembolization in hepatocellular carcinoma: multivariate analysis of survival prognostic factors after the first session].
    El Khaddari S; Gaudin JL; Abidi H; Picaud G; Rode A; Souquet JC
    Gastroenterol Clin Biol; 2002; 26(8-9):728-34. PubMed ID: 12434077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Study of local three-dimensional conformal radiotherapy combined with transcatheter arterial chemoembolization for patients with stage III hepatocellular carcinoma.
    Li B; Yu J; Wang L; Li C; Zhou T; Zhai L; Xing L
    Am J Clin Oncol; 2003 Aug; 26(4):e92-9. PubMed ID: 12902905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transarterial chemoembolization with cisplatin as second-line treatment for hepatocellular carcinoma unresponsive to chemoembolization with epirubicin-Lipiodol emulsion.
    Maeda N; Osuga K; Higashihara H; Tomoda K; Mikami K; Nakazawa T; Nakamura H; Tomiyama N
    Cardiovasc Intervent Radiol; 2012 Feb; 35(1):82-9. PubMed ID: 21203761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic factors for survival after transarterial chemoembolization combined with microwave ablation for hepatocellular carcinoma.
    Ni JY; Sun HL; Chen YT; Luo JH; Chen D; Jiang XY; Xu LF
    World J Gastroenterol; 2014 Dec; 20(46):17483-90. PubMed ID: 25516662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.